TGFB1 and neoplasm: Equilibrium in immunoediting illustrates humoral levels of low anti-tumor (Interleukin-12 (IL-12), IFN-γ) cytokines compared with high tumor-promoting cytokines (TGF-β, IL-10, IL-23) [194,195,196,197,198].